$115 Million is the total value of Sonic Fund II, L.P.'s 12 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -112,689 | -100.0% | -14.93% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ADVERUM BIOTECHNOLOGIES INC | 12 | Q3 2022 | 47.8% |
GENWORTH FINL INC | 12 | Q3 2022 | 14.5% |
FENNEC PHARMACEUTICALS INC | 12 | Q3 2022 | 13.2% |
REGENXBIO INC | 12 | Q3 2022 | 19.6% |
TRONOX HOLDINGS PLC | 12 | Q3 2022 | 3.3% |
SPIRIT AIRLS INC | 11 | Q3 2022 | 8.7% |
US FOODS HLDG CORP | 11 | Q3 2022 | 7.7% |
RADIAN GROUP INC | 11 | Q3 2022 | 4.1% |
HAWAIIAN HOLDINGS INC | 11 | Q3 2022 | 4.5% |
UNITED AIRLS HLDGS INC | 10 | Q3 2022 | 4.9% |
View Sonic Fund II, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Adverum Biotechnologies, Inc. | December 30, 2022 | 4,552,068 | 4.6% |
FENNEC PHARMACEUTICALS INC. | February 14, 2022 | 2,407,357 | 9.3% |
View Sonic Fund II, L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
SC 13D/A | 2022-12-30 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
SC 13G/A | 2022-02-14 |
View Sonic Fund II, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.